AGK and renal cell carcinoma: RCC patients with higher AGK expression experienced poorer 5-year OS (64% vs. 96%, P <  0.001, Fig. 1g) and 5-year DMFS (57% vs. 95%, P <  0.001, Fig. 1h) than patients with low AGK expression.